164 related articles for article (PubMed ID: 20879056)
1. Standardized combination antibiotic treatment of Mycobacterium avium complex lung disease.
Sim YS; Park HY; Jeon K; Suh GY; Kwon OJ; Koh WJ
Yonsei Med J; 2010 Nov; 51(6):888-94. PubMed ID: 20879056
[TBL] [Abstract][Full Text] [Related]
2. Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease.
Adachi Y; Tsuyuguchi K; Kobayashi T; Kurahara Y; Yoshida S; Kagawa T; Hayashi S; Suzuki K
J Infect Chemother; 2020 Jul; 26(7):676-680. PubMed ID: 32171660
[TBL] [Abstract][Full Text] [Related]
3. The effect of combined therapy according to the guidelines for the treatment of Mycobacterium avium complex pulmonary disease.
Kobashi Y; Matsushima T
Intern Med; 2003 Aug; 42(8):670-5. PubMed ID: 12924489
[TBL] [Abstract][Full Text] [Related]
4. The clinical efficacy of a clarithromycin-based regimen for Mycobacterium avium complex disease: A nationwide post-marketing study.
Kadota JI; Kurashima A; Suzuki K
J Infect Chemother; 2017 May; 23(5):293-300. PubMed ID: 28254517
[TBL] [Abstract][Full Text] [Related]
5. Treatment of refractory Mycobacterium avium complex lung disease with a moxifloxacin-containing regimen.
Koh WJ; Hong G; Kim SY; Jeong BH; Park HY; Jeon K; Kwon OJ; Lee SH; Kim CK; Shin SJ
Antimicrob Agents Chemother; 2013 May; 57(5):2281-5. PubMed ID: 23478956
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study.
Miwa S; Shirai M; Toyoshima M; Shirai T; Yasuda K; Yokomura K; Yamada T; Masuda M; Inui N; Chida K; Suda T; Hayakawa H
Ann Am Thorac Soc; 2014 Jan; 11(1):23-9. PubMed ID: 24298907
[TBL] [Abstract][Full Text] [Related]
7.
Kwon BS; Kim MN; Sung H; Koh Y; Kim WS; Song JW; Oh YM; Lee SD; Lee SW; Lee JS; Lim CM; Choi CM; Huh JW; Hong SB; Park S; Shim TS; Chong YP; Jo KW
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012759
[TBL] [Abstract][Full Text] [Related]
8. The microbiological and clinical effects of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease in Japan - including a follow-up study.
Kobashi Y; Matsushima T
Respiration; 2007; 74(4):394-400. PubMed ID: 16954651
[TBL] [Abstract][Full Text] [Related]
9. Macrolide resistant Mycobacterium avium complex pulmonary disease following clarithromycin and ethambutol combination therapy.
Ito Y; Miwa S; Shirai M; Kanai M; Fujita K; Ohba H; Iwaizumi E; Oshima T; Kojima S; Suda T; Hayakawa H
Respir Med; 2020 Aug; 169():106025. PubMed ID: 32442113
[TBL] [Abstract][Full Text] [Related]
10. Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease.
Kadota T; Matsui H; Hirose T; Suzuki J; Saito M; Akaba T; Kobayashi K; Akashi S; Kawashima M; Tamura A; Nagai H; Akagawa S; Kobayashi N; Ohta K
BMC Infect Dis; 2016 Jan; 16():31. PubMed ID: 26818764
[TBL] [Abstract][Full Text] [Related]
11. Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease.
Kim HJ; Lee JS; Kwak N; Cho J; Lee CH; Han SK; Yim JJ
BMC Pulm Med; 2019 Nov; 19(1):212. PubMed ID: 31711459
[TBL] [Abstract][Full Text] [Related]
12. Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease.
Jeong BH; Jeon K; Park HY; Kim SY; Lee KS; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
Am J Respir Crit Care Med; 2015 Jan; 191(1):96-103. PubMed ID: 25393520
[TBL] [Abstract][Full Text] [Related]
13. Changes in serum immunomolecules during antibiotic therapy for Mycobacterium avium complex lung disease.
Kim SY; Koh WJ; Park HY; Jeon K; Kwon OJ; Cho SN; Shin SJ
Clin Exp Immunol; 2014 Apr; 176(1):93-101. PubMed ID: 24354934
[TBL] [Abstract][Full Text] [Related]
14. Long-term Follow-up of Mycobacterium avium Complex Lung Disease in Patients Treated With Regimens Including Clofazimine and/or Rifampin.
Jarand J; Davis JP; Cowie RL; Field SK; Fisher DA
Chest; 2016 May; 149(5):1285-93. PubMed ID: 26513209
[TBL] [Abstract][Full Text] [Related]
15. Treatment outcome of combination therapy including clarithromycin for Mycobacterium avium complex pulmonary disease.
Kim EY; Chi SY; Oh IJ; Kim KS; Kim YI; Lim SC; Kim YC; Kwon YS
Korean J Intern Med; 2011 Mar; 26(1):54-9. PubMed ID: 21437163
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease.
Koh WJ; Jeong BH; Jeon K; Lee SY; Shin SJ
Am J Respir Crit Care Med; 2012 Oct; 186(8):797-802. PubMed ID: 22878282
[TBL] [Abstract][Full Text] [Related]
17. Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease.
Tanaka E; Kimoto T; Tsuyuguchi K; Watanabe I; Matsumoto H; Niimi A; Suzuki K; Murayama T; Amitani R; Kuze F
Am J Respir Crit Care Med; 1999 Sep; 160(3):866-72. PubMed ID: 10471610
[TBL] [Abstract][Full Text] [Related]
18. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease.
Ye JJ; Wu TS; Chiang PC; Lee MH
J Microbiol Immunol Infect; 2007 Aug; 40(4):342-8. PubMed ID: 17712469
[TBL] [Abstract][Full Text] [Related]
19. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates.
Kobashi Y; Yoshida K; Miyashita N; Niki Y; Oka M
J Infect Chemother; 2006 Aug; 12(4):195-202. PubMed ID: 16944258
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Fluoroquinolones as Substitutes for Ethambutol or Rifampin in the Treatment of Mycobacterium avium Complex Pulmonary Disease According to Radiologic Types.
Lee JH; Park YE; Chong YP; Shim TS; Jo KW
Antimicrob Agents Chemother; 2022 Feb; 66(2):e0152221. PubMed ID: 34930036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
